Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis - Zhao, Qing; Zhang, Jianwei; Xu, Lingyi; Yang, Huaxia; Liang, Naixin; Zhang, Li; Zhang, Fengchun; Zhang, Xuan (Frontiers in immunology, 2021)
Keywords: cancer; Drug-Related Side Effects and Adverse Reactions - diagnosis; Drug-Related Side Effects and Adverse Reactions - epidemiology; Drug-Related Side Effects and Adverse Reactions - immunology; efficacy; Humans; immune checkpoint inhibitors; Immune Checkpoint Inhibitors - administration & dosage; Immune Checkpoint Inhibitors - adverse effects; immune-related adverse events; Immunology; Incidence; Neoplasms - drug therapy; Neoplasms - immunology; rechallenge; Retreatment; Risk Assessment; Risk Factors; safety; Severity of Illness Index; Treatment Outcome; cancer; immune checkpoint inhibitors; rechallenge; safety; efficacy; immune-related adverse events